Life Sciences

This issue of Vital Signs, released on July 11, 2014, discusses game changing strategies in clinical research, including virtual clinical research organization (CRO) and the integrated business model.

This study provides an analysis of the US market for molecular imaging informatics solutions including nuclear imaging informatics, PET imaging informatics, and multimodality image fusion and comparison. The study assesses the size of the market based on its historic growth between 2010 and 2013, and projects future growth based on the current driv...

Medical devices plays a key role in a vibrant healthcare industry. An increasing aging population with increasing communicable and non-communicale diseases and most governments providing subisidized healthcare translate the need for cost-effective medical devices. Governments need to meet these expectations by policy librealization and revamping re...

This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...

This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogens Eloctate, Qiagens acquisition of Primera Dx, Roches acquisition of Genia Technologies, Cues at-home connected lab test, and the Credihealth Teen Clinic.

There are a number of factors that influence a life sciences companys decision in selecting the perfect location for its research and development (R&D), manufacturing operations, or headquarters. This Vital Signs article discusses those factors and discusses why Carlsbad, California, is one ideal Life Sciences hub location. Case studies include I...

This Market Insight highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics (IVD) market, diagnostic test service providers, and IVD manufacturers. The deliverable also focuses on global trends and the outlook for the IVD market. Estimates and trends for all IVD segmentsimmunochemistry, point-of-care...

This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the d...

This study provides data for the Western European in vitro diagnostics (IVD) market. Haematology, haemostasis, urinalysis, microbiology, clinical chemistry, point-of-care testing, molecular diagnostics, tissue diagnostics, self-monitoring blood glucose and immunochemistry are the segments within this market. Market revenues have been included in th...